Protocol Citation: Stefania S Policicchio, Isabel Castanho, Barry Chioza, Joe Burrage, Jonathan Mill, Emma L Dempster, Jonathan P Davies 2022. Fluorescence-activated nuclei sorting (FANS) of purified neural cell populations from mouse cortex for multi-omic profiling. protocols.io https://dx.doi.org/10.17504/protocols.io.dm6gpbwndlzp/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Increased understanding of the functional complexity of the genome has led to growing recognition about the role of epigenetic/transcriptional variation in health and disease. Because epigenetic processes play a critical role in determining cell type-specific patterns of gene regulation it is important to consider cellular composition in regulatory genomic studies of heterogeneous tissue like the brain. Building on a previous protocol for isolating purified populations of nuclei from different cortical cell types from human post-mortem brain tissue, this protocol uses fluorescence-activated nuclei sorting (FANS) to isolate and profile nuclei from multiple different cell types from frozen mouse cortex. This protocol can be used to robustly purify populations of neuronal (NeuN+ve) and microglia (PU.1+ve) and other glial origin nuclei (NeuN-ve/PU.1-ve) from frozen mouse cortex tissue, with each sample yielding purified populations of nuclei amenable to simultaneous analysis of i) DNA modifications (via bisulfite sequencing/microarray), ii) histone modifications (via CUT&RUN-seq), iii) chromatin accessibility (via ATAC-seq), and iv) gene expression (via RNA-seq).
Materials
A
B
C
Equipment
Supplier
Catalogue No
BD FACSAria™ III Cell Sorter
BD Biosciences
648282-23
Sorvall WX 80+ Ultracentrifuge
Thermo Scientific™
75000080
1mL Dounce Tissue Grinder
Sigma-Aldrich
DWK885300-0001-1EA
PA Thin-walled ultracentrifuge tubes
Thermo Scientific
03699
Table 1:Specifications of the equipment required for FANS protocol
A
B
C
Reagent name
Supplier
Catalogue No
D-Sucrose (Molecular Biology)
Fisher Scientific
10638403
Calcium chloride (CaCl2) anhydrous, granular
Sigma-Aldrich
C1016-100G
Magnesium acetate ( Mg(Ace)2), 1M aq. soln
Alfa Aesar
J60041
UltraPure™ 0.5M EDTA, pH 8.0
Invitrogen
15575020
UltraPure™ 1M Tris-HCI Buffer, pH 8.0
Fisher Scientific
15568025
1,4-Dithiothreitol (DTT) - crystalline powder
Sigma-Aldrich
3483-12-3
Triton™ X-100
Sigma-Aldrich
T9284
UltraPure™ DNase/RNase-Free Distilled Water
Fisher Scientific
12060346
Bovine Serum Albumin (BSA)
Sigma-Aldrich
A9647-500G
PBS Phosphate-Buffered Saline (10X) pH 7.4
Fisher Scientific
10722497
RNasin® Plus RNase Inhibitor
Promega
PAN2615
TRIzol™ LS Reagent
Invitrogen™
11588616
BAMBANKER™ serum free cell freezing medium
BioCat GmbH
BB03-NP
BD FACSDiva CS&T Research Beads
BD biosciences
655051
BD FACS™ Accudrop Beads
BD biosciences
345249
BD FACSFlow™ Sheath Fluid 20L
BD Scientific
342003
BD FACS Clean Solution
BD Scientific
15875858
BD FACSRinse Solution
BD Scientific
340346
Table 2 : Specification of reagents required for FANS protocol
A
B
Lysis Buffer (LB)
0.32M Sucrose
5.47 g
5mM CaCl2
250 µL
3mM Mg(Ace)2
150 µL
0.1mM EDTA
10 µL
10mM Tris-HCl, pH 8
500 µL
1mM DTT
17 µL
0.1% Triton X-100
50 µL
Adjust with ddH2O to
50 mL
1.8M Sucrose Solution (SS)
1.8M Sucrose
30.78 g
3mM Mg(Ace)2
150 µL
1mM DTT
17 µL
10mM Tris-HCl, pH8
500 µL
Adjust with ddH2O to
50 mL
5% BSA Solution (BB)
BSA
200 mg
Dissolve in 1x PBS
4 mL
Optional: RNasin® Plus RNase Inhibitor
2 µL / 1mL
Staining Buffer (SB)
5% BSA
500 µL
10X PBS
500 µL
ddH2O
4 mL
Final Volume
5 mL
Table 3 : Recipes for buffers and solutions required
Supplier
Thermo Scientific™
Model
Sorvall™ WX 80+
Rotor
TH-641
Speed
25,200 RPM / 108670.8 x g
Acceleration
9
Deceleration
5
Temperature
4°C
Table 4 : Ultracentrifuge specification and conditions
A
B
C
D
E
Antibody
Preconjugated
Supplier
Cat No
Dilution
Hoechst 33342
--
Abcam
ab228551
1:500
Anti-NeuN
to Alexa Fluor488
Abcam
ab190195
1:1000
Anti-PU.1
to PE
BioLegend
681308
1:100
Table 5 : List of antibodies required for FANS protocol
Figure S1 : Schematic overview showing the array of downstream applications for which FANS-processed nuclei are suitable
Nuclear prep for FACS separation (using NeuN, PU.1 and Hoechst)
Nuclear prep for FACS separation (using NeuN, PU.1 and Hoechst)
55m
55m
In our hands the protocol below yields ~60,000 NeuN +ve (neuron enriched), ~5,000 PU.1 +ve (microglial enriched) and ~20,000 double negative (NeuN-ve/PU.1-ve; oligodendrocyte enriched) nuclei per ≤ 100 mg of frozen mouse cortex tissue. Recovery might vary from sample to sample due to high inter-sample variability and regional differences across cortical areas (i.e. dissection procedure, fat content of tissue sectioned, age).
Refer to Materials-Table 1 for details about the equipment required and to Materials-Table 2 for specifications of reagents required.
Solution and buffer preps
Lysis Buffer (LB)
Sucrose Solution (SS)
Staining Buffer (SB)
Solutions should be kept at 4 °C or On ice . Refer to Materials -Table 3 for recipes of solutions and buffers.
Note
NOTE 1 – LB and SS can be prepared a week in advance, with DTT added on the day of use. Solutions should be stored at 4 °C once made.
Note
NOTE 2 – SB should be prepared fresh each day.
Note
NOTE 3- Samples are homogenised as bulk tissue using a 1 mL Dounce homogeniser and then equally divided into two ultracentrifuge tubes.
Nuclei isolation
1.Pre-cool the ultracentrifuge to 4 °C before starting this stage of the protocol.
2.All buffers and the Dounce homogenisers should be pre-cooled on ice.
4. Add 1 mM DTT to the SS and LB according to the recipe (i.e. 17 µL per 50 mL of SS/LB)
5. Transfer 1 mL LB into each homogeniser
6. Add the dissected tissue sample into the homogeniser
7. Wait 3-5 minutes before douncing the tissue to allow the sample to defrost
To reduce heat caused by friction, the Dounce homogenisation step should be performed on ice with gentle strokes, and care should be taken to avoid foaming.
Note
NOTE 1 – Using the "TIGHT" pestle helps reduce the number of strokes required to reach full tissue disruption.
Note
NOTE 2 - The number of strokes required to fully homogenise the tissue may vary between samples due to heterogeneity in cellular composition, lipid content, and the amount of connective tissue.
Figure 1 Example of brain tissue sample A) only partially homogenised B) complete homogenisation
8. Transfer 8 mL SS (1.8M) to PA thin-walled ultracentrifuge tubes
9. Carefully overlay with tissue homogenate (1 mL per tube) - using a P1000 pipette, releasing slowly down the side of the tube
10. Add 1mL LB back into the homogeniser to rinse and recover as much as possible of the residual homogenate left behind
11. Recover volume from homogeniser and overlay it on homogenate phase
12. Balance opposite tubes by weight with 1x PBS using a fine microbalance
13. Perform ultracentrifugation for 00:35:00 (see Table 4 for centrifuge specification and conditions)
35m
After Ultracentrifugation step
Aspirate supernatant leaving 1-2 mL of the solution in the tube along with the pellet.
Pour off any remaining supernatant, taking care not to dislodge the pellet (90-degree inclination of the tube). If the pellet is hard to see, it is okay to leave 100-200 µL solution in the ultracentrifuge tube
Resuspend pellet in SB (1 mL), gently pipette up and down
Let samples sit On ice for 00:15:00 at least (Blocking step)
Transfer volume into a new 1.5 mL tube
Rinse out ultracentrifuge tubes in order to maximise nuclei collection by adding 1 extra mL of SB per tube, pipetting up and down several times, and transferring into a new 1.5 mL tube
Washing step: 1.4 x g, 4°C for 00:05:00
Discard supernatant (pipetting off gently)
Re-suspend each nuclei pellet in fresh SB (500 µL)
If the sample was split then pool together resuspended pellets from the same sample (Final Volume = 1 mL)
Add DNA dye (Hoechst, 2 µL/1 mL) and mix thoroughly by inversion.
Pipette out 120 µL of nuclei solution for the Unstained Control (Hoechst dye only) and transfer to a new 1.5 mL tube
Bring the volume up to 500 µL for the Unstained tube with fresh SB
Replace the volume taken from the "Stained" tube with 120 µL of fresh SB (Final Volume = 1 mL)
20m
Immunostaining
1. Add the following three antibodies (Ab) to the "Stained" tube (1mL final volume):
PE anti-PU.1 (1:100 dilution) – [10 µL Ab]
Alexa488 anti-NeuN (1:1000) – [2 µL Ab ]
Refer to Table 5 for specifications of the antibodies used
2. Incubate tubes for 01:30:00 on the rotor (speed=14 max) at 4 °C keeping the tubes in the dark
3. Washing step: 1.4 x g, 4°C for 00:05:00 (both "Stained" and "Unstained" tubes)
4. Discard supernatant (by pipetting off)
5. Re-suspend in fresh SB (500 µL for the Unstained tube, 1 mL for the Stained tube - depending on pellet size)
1h 35m
Fluorescence-Activated Nuclei Sorting (FANS)
Fluorescence-Activated Nuclei Sorting (FANS)
For machine start-up, CST and Accudrop calibrations refer to BD FACSAria III User’s Guide for guidance and troubleshooting. The following instructions describe FANS using BD FACSAria III. Other FACS platforms can be used but might require modifications to the protocol.
General Gating Parameters
For each sample, load stained and unstained tubes individually for data acquisition. A preliminary qualitative analysis of the data acquired is essential to select the appropriate gating strategy to maximise the nuclei capture while excluding unnecessary debris and to ensure an optimal signal/noise ratio.
Gating Parameters (X-axis: Y-axis):
FSC-A:SSC-A (Size, cell granularity or internal complexity)
SSC-W:SSC-A (to gate out doublets)
FSC-A:DAPI-A (to gate the single nuclei population)
DAPI-A:FITC-A (to gate NeuN stained nuclei)
DAPI-A:PE-A (to gate PU.1 stained nuclei)
FITC-A: PE-A (to visualize the distribution of the three detectable populations)
Note
The PU.1+ve population (microglia) is gated as a “daughter” population from the NeuN-ve fraction (non neuronal nuclei). Refer to Figure 2 for a visualization of the gating strategy.
Figure 2. FANS gating strategy. (a) Particles smaller than nuclei (black dots) were eliminated with an area plot of forward-scatter (FSC-A) versus side-scatter (SSC-A), with gating for nuclei-sized particles inside the gate (box). (b) Plots of height versus width in the side scatter channel are used for doublet discrimination with gating to exclude aggregates of two or more nuclei. (c) Doublet discrimination gating was used to isolate nuclei determined by sub-gating on Hoechst 33342. (d, f)Subsequent scatterplots discerning (d) NeuN-Alexa Fluor488–conjugated antibody staining (purple) (e) PU.1 PE-stained nuclei (dark pink) (f) the distribution of the three main nuclei subpopulations identified through double staining strategy (NeuN +ve, neurons; PU.1+ve, microglia, double–ve, oligodendrocytes enriched). The resultant hierarchical colour key ensures that only nuclei that are negative for staining with the NeuN antibody are passed through the next gating condition.
Data recording settings
In line with the experiment design, FSC, SSC, DAPI, FITC and PE are the parameters for which voltage values may need to be slightly adjusted due to experiment/ inter-sample variability.
It is advisable to set the threshold value between 200 and 500 during data recording. Moreover, in the acquisition dashboard tab, we recommend setting Events to Record≤3,000, Event to display≤5000 and Flow Rate = 1.0 (1,000 events per second) in order to increase the accuracy of signal detection.
The flow rate can be increased during sample collection to reduce the sort speed (ideally max events per second =1,500 for a 100-micron nozzle). However higher flow rates impact the data resolution and accuracy of events detection, and subsequent sorting of cellular fractions (seeBD FACSAria III User’s Guide for details).
During analysis, recorded data is displayed in plots, while gates are used to define populations of interest for selection. Figure 3 shows a representative example of the two most common outcomes we often observe.
Figure 3. Representative example of inter-individual variability. The data shown here are derived from two different cortex specimens of comparable age, sex, and group which were processed in parallel following the same procedure. A) distinctly separated PU.1 +ve fraction vs B) missing PU.1+ve positively stained population.
Sample Collection
LoBind Tubes (Eppendorf, Cat No:30108051) are required to collect nuclei (to maximise sample recovery of nucleic acids by significantly reducing sample–to–surface binding).
Nuclei are collected in 150 µL BAMBANKER (up to 1,000,000 nuclei) if collecting for chromatin or DNA assays. Nuclei are collected in Trizol LS Reagent (500 µL) if you are collecting for RNA.
Collected fractions can be used directly for downstream applications (e.g. DNA/RNA extraction, chromatin shearing) or frozen at -80 °C for long term storage. We recommend not to pellet nuclei down prior freezing to prevent nuclei loss due to nuclei bursting/ damage.
Note
NOTE - During collection, it is crucial to regularly pause the sorting to mix the two phases by inversions in order to preserve the integrity of resulting RNA preparations.
For RNA extraction, LoBind Tubes should each contain 500µL of pre-chilled TRIzol™ LS Reagent (Fisher Scientific, Cat No: 11578616) prior to sorting.
4. Keep samples on ice for the entire duration of the sorting
5. Lightly vortex sample tubes to make the mixture homogeneous (not clumped) before loading the tube into the FACS chamber
6. Load the UNSTAINED control tube into the chamber first and proceed with nuclei collection (for DNA, 200,000 events; for RNA, 300,000 events; for ATAC-seq 50,000 events). Refer to Materials - Figure S1 for the full range of applications sorted nuclei can be used.
7. Proceed by collecting STAINED tube by simultaneously sorting for NeuN and PU.1
Note
The PU.1+ve population may not be detectable in every brain sample processed (high inter-individual variability); when it is, it represents between 5-10% of the total sample, therefore yielding often insufficient material for multiple assays.
General Recommendations for the user
General Recommendations for the user
For every new experiment we recommend performing the following steps:
When loading your tube into the FACS machine, run the unstained / IgG control sample first as this aids in setting the baseline parameters
Check your event rate in the Acquisition Dashboard window. If it is greater than 1500 evt/s turn down the “flow rate” or unload and dilute the sample further. If less than 100 evt/s, turn up the “flow rate” (don’t exceed a flow rate of 5.0 if possible, as the instrument is less focused and more inaccurate at higher flow rates)
In the Acquisition Dashboard window choose the appropriate “stopping gate” and “storage gate” (when working with nuclei, set as “Nuclei” and “All events” respectively)
Choose the range of “events to record” and “events to display” that best suits your purpose (≥ 5000 for both is advised)
Under the “threshold” tab in the Cytometer window, change the threshold (should be set for FSC) so that any small events in the bottom corner of the FSC vs SSC graph (caused by general cell debris and dust) are no longer shown. The threshold should not be set too high so that it causes an arbitrary, artificial cut-off through the left side of your population but not so low that small events caused by debris/dust are visible (ideally between a threshold 200-500).
Under the “parameters” tab in the Cytometer window, adjust the “FSC” and “SSC” values to get your population sitting in the centre of the FSC vs SSC graph (a re-adjustment of the “threshold” may be required at this point). It is essential to select “restart” each time any of the parameters are changed to update the events being displayed to ensure only events are recorded under the new settings.
Adjust or draw a new gate in the FSC vs SSC plot to encompass the population of interest.
Look in the scatter graph of SSC-A vs SSC-W (if you opened a blank experiment you will need to draw one). Right-click on the graph and check it is only displaying the events encompassed by your previous FSC vs SSC gate. Adjust or draw a gate for SSC-A vs SSC-W to encompass all the main population to the left of the graph and exclude outliers to the right (these are doublets and other cell debris clumps)
Under the “parameters” tab in the Cytometer window adjust parameters for the fluorochromes selected so the unstained / IgG control sample sits close to 0 for the fluorochrome on a graph of FSC vs fluorochrome.
Load the stained samples and check the stained population has a clear increase in signal for the fluorochrome in comparison to the unstained (signal should not exceed 104). Several minor re-adjustments of the fluorochrome’s “parameters" may be necessary for the stained sample at this stage. If so, the unstained / IgG control must be reset and re-recorded.
Note
WARNING – Do not change parameter settings between samples you wish to compare, if you do you will need to re-record all samples using the changed parameters.
11. Select the correct option for the collection device in the Sort Layout window ( we recommend “4-Way Purity” for general collection)
12. Regularly check your “Efficiency” in the Sort Layout window value. Between 80-100% is ideal, 70% is acceptable if less than 70% either the sample is too concentrated or you are sorting a rare population. Although the “flow rate” in the Acquisition Dashboard window can be increased to make the sort quicker, faster flow rates are less efficient.
13. Check the “Electronic abort rate” (N° errors /sec) and “Electronic abort count” (Tot N° of errors) at the bottom of the Acquisition Dashboard window. These parameters measure potential miss-sorts (different from efficiency as efficiency measures undetermined drops which are directed to the “Waste” and therefore lost but do not contaminate).“Electronic abort rate” should be <1% of total events per second.
14. For long sorts, gate positions should be regularly monitored, especially for stained populations as fluorochromes lose intensity over time and the population can shift towards the unstained. Gates can be moved during long sorts to compensate.